The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
TMPRSS2 is regulated by androgen receptor signalling in the prostate, however it is unclear if blocking this signalling is beneficial in the context of SARS-CoV-2 lung infection. Here the authors show that antiandrogen treatment downregulates TMPRSS2 in the lung and reduces viral entry and infection...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/054d5eddfbac4f51bb25f10d584c7186 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:054d5eddfbac4f51bb25f10d584c7186 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:054d5eddfbac4f51bb25f10d584c71862021-12-02T16:31:43ZThe antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells10.1038/s41467-021-24342-y2041-1723https://doaj.org/article/054d5eddfbac4f51bb25f10d584c71862021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24342-yhttps://doaj.org/toc/2041-1723TMPRSS2 is regulated by androgen receptor signalling in the prostate, however it is unclear if blocking this signalling is beneficial in the context of SARS-CoV-2 lung infection. Here the authors show that antiandrogen treatment downregulates TMPRSS2 in the lung and reduces viral entry and infection.D. A. LeachA. MohrE. S. GiotisE. CilA. M. IsacL. L. YatesW. S. BarclayR. M. ZwackaC. L. BevanG. N. BrookeNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q D. A. Leach A. Mohr E. S. Giotis E. Cil A. M. Isac L. L. Yates W. S. Barclay R. M. Zwacka C. L. Bevan G. N. Brooke The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells |
description |
TMPRSS2 is regulated by androgen receptor signalling in the prostate, however it is unclear if blocking this signalling is beneficial in the context of SARS-CoV-2 lung infection. Here the authors show that antiandrogen treatment downregulates TMPRSS2 in the lung and reduces viral entry and infection. |
format |
article |
author |
D. A. Leach A. Mohr E. S. Giotis E. Cil A. M. Isac L. L. Yates W. S. Barclay R. M. Zwacka C. L. Bevan G. N. Brooke |
author_facet |
D. A. Leach A. Mohr E. S. Giotis E. Cil A. M. Isac L. L. Yates W. S. Barclay R. M. Zwacka C. L. Bevan G. N. Brooke |
author_sort |
D. A. Leach |
title |
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells |
title_short |
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells |
title_full |
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells |
title_fullStr |
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells |
title_full_unstemmed |
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells |
title_sort |
antiandrogen enzalutamide downregulates tmprss2 and reduces cellular entry of sars-cov-2 in human lung cells |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/054d5eddfbac4f51bb25f10d584c7186 |
work_keys_str_mv |
AT daleach theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT amohr theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT esgiotis theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT ecil theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT amisac theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT llyates theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT wsbarclay theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT rmzwacka theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT clbevan theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT gnbrooke theantiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT daleach antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT amohr antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT esgiotis antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT ecil antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT amisac antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT llyates antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT wsbarclay antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT rmzwacka antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT clbevan antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells AT gnbrooke antiandrogenenzalutamidedownregulatestmprss2andreducescellularentryofsarscov2inhumanlungcells |
_version_ |
1718383853144375296 |